TSH and fT4 during pregnancy: an observational study and a review of the literature
-
Annemiek M.C.P. Joosen
, Ivon J.M. van der Linden
Abstract
Background: Trimester-specific reference intervals for TSH are recommended to assess thyroid function during pregnancy due to changes in thyroid physiology. Laboratories should verify reference intervals for their population and assay used. No consistent upper reference limit (URL) for TSH during pregnancy is reported in literature. We investigated the use of non-pregnant reference intervals for TSH, recommended during pregnancy by current Dutch guidelines, by deriving trimester-specific reference intervals in disease-free Dutch pregnant women as these are not available.
Methods: Apparently healthy low risk pregnant women were recruited via midwifery practices. Exclusion criteria included current or past history of thyroid or other endocrine disease, multiple pregnancy, use of medication known to influence thyroid function and current pregnancy as a result of hormonal stimulation. Women who were TPO-antibody positive, miscarried, developed hyperemesis gravidarum, hypertension, pre-eclampsia, HELLP, diabetes or other disease, delivered prematurely or had a small for gestational age neonate were excluded. Blood samples were collected at 9–13 weeks (n=99), 27–29 weeks (n=96) and 36–39 weeks (n=96) of gestation and at 4–13 weeks post-partum (n=95). Sixty women had complete data during pregnancy and post-partum. All analyses were performed on a Roche Cobas e601 analyser.
Results and conclusions: In contrast to current Dutch guidelines, the 97.5th percentiles of TSH in the first (3.39 mIU/L) and second trimesters (3.38 mIU/L) are well under the non-pregnant URL of 4.0 mIU/L. The higher TSH in the third trimester (97.5th percentile 3.85 mIU/L) is close to the current non-pregnant URL of 4.0 mIU/L. Absolute intra-individual TSH is relatively stable during pregnancy and post-partum as individuals tracked within the tertile assigned in trimester 1. Even small deviations within the population reference interval may indicate subtle thyroid dysfunction.
Acknowledgments
We gratefully acknowledge primary midwife practices Verloskundigen Etten-Leur, Trivia, De Moriaen, Doortje Uil, Verloskundig Centrum Breda, Het Zomerhuis, Prinsenbeemden, Het Klavertje, Luna, Vita and De Ooievaar and Origine birth center for recruitment of the volunteers. We thank Roche for providing the test kits.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Balucan FS, Morshed SA, Davies TF. Thyroid autoantibodies in pregnancy: their role, regulation and clinical relevance. J Thyroid Res 2013;2013:182472.10.1155/2013/182472Search in Google Scholar PubMed PubMed Central
2. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005;105:239–45.10.1097/01.AOG.0000152345.99421.22Search in Google Scholar PubMed
3. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012;97:2543–65.10.1210/jc.2011-2803Search in Google Scholar PubMed
4. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and post-partum. Thyroid 2011;21:1081–125.10.1089/thy.2011.0087Search in Google Scholar PubMed PubMed Central
5. Ekinci EI, Lu ZX, Sikaris K, Bittar I, Cheong KY, Lam Q, et al. Longitudinal assessment of thyroid function in pregnancy. Ann Clin Biochem 2013;50:595–602.10.1177/0004563213486450Search in Google Scholar PubMed
6. Ekinci EI, Chiu WL, Lu ZX, Sikaris K, Churilov L, Bittar I, et al. A longitudinal study of thyroid autoantibodies in pregnancy: the importance of test timing. Clin Endocrinol 2015;82:604–10.10.1111/cen.12571Search in Google Scholar PubMed
7. Boas M, Forman JL, Juul A, Feldt-Rasmussen U, Skakkebaek NE, Hilsted L, et al. Narrow intra-individual variation of maternal thyroid function in pregnancy based on a longitudinal study on 132 women. Eur J Endocrinol 2009;161:903–10.10.1530/EJE-09-0579Search in Google Scholar PubMed
8. Karakosta P, Chatzi L, Bagkeris E, Daraki V, Alegakis D, Castanas E, et al. First- and second-trimester reference intervals for thyroid hormones during pregnancy in “Rhea” mother-child chort, Crete, Greece. J Thyroid Res 2011;2011:490783.10.4061/2011/490783Search in Google Scholar PubMed PubMed Central
9. Khalid AS, Marchocki Z, Hayes K, Lutomski JE, Joyce C, Stapleton M, et al. Establishing trimester-specific maternal thyroid function reference intervals. Ann Clin Biochem 2014;51:277–83.10.1177/0004563213496394Search in Google Scholar PubMed
10. Quinn FA, Reyes-Mendez MA, Nicholson L, Compean LP, Tavera ML. Thyroid function and thyroid autoimmunity in apparently healthy pregnant and non-pregnant Mexican women. Clin Chem Lab Med 2014;52:1305–11.10.1515/cclm-2014-0350Search in Google Scholar PubMed
11. Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, van der Wal MF, Bonsel GJ. Ethnic differences in TSH but not in free T4 concentrations or TPO antibodies during pregnancy. Clin Endocrinol 2007;66:765–70.10.1111/j.1365-2265.2007.02803.xSearch in Google Scholar PubMed
12. Medici M, de Rijke YB, Peeters RP, Visser W, de Muinck Keizer-Schrama SM, Jaddoe VV, et al. Maternal early pregnancy and newborn thyroid hormone parameters: the Generation R study. J Clin Endocrinol Metab 2012;97:646–52.10.1210/jc.2011-2398Search in Google Scholar PubMed
13. Monen L, Kuppens S, Hasaart T, Oosterbaan H, Oei S, Wijnen H, et al. Maternal thyrotropin is independently related to small for gestational age neonates at term. Clin Endocrinol (Oxf) 2015;82:254–9.10.1111/cen.12578Search in Google Scholar PubMed
14. Bocos-Terraz JP, Izquierdo-Alvarez S, Bancalero-Flores JL, Alvarez-Lahuerta R, Aznar-Sauca A, Real-López E, et al. Thyroid hormones according to gestational age in pregnant Spanish women. BMC Res Notes 2009;2:237.10.1186/1756-0500-2-237Search in Google Scholar PubMed PubMed Central
15. Stricker R, Echenard M, Eberhart R, Chevailler MC, Perez V, Quinn FA, et al. Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol 2007;157:509–14.10.1530/EJE-07-0249Search in Google Scholar PubMed
16. Nederlandsche Internisten Vereeniging. Richtlijn Schildklierfunctiestoornissen. Utrecht: NIV; 2012.Search in Google Scholar
17. Health Council of The Netherlands. Towards maintaining an optimal iodine intake. Publication no 2008/14. The Hague, The Netherlands, 2008.Search in Google Scholar
18. Hendriksen MA, van Raaij JM, Geleijnse JM, Wilson-van den Hooven C, Ocké MC, van der ADL. Monitoring salt and iodine intakes in Dutch adults between 2006 and 2010 using 24 h urinary sodium and iodine excretions. Public Health Nutr 2014;17:1431–8.10.1017/S1368980013001481Search in Google Scholar PubMed
19. Ehrenkranz J, Bach PR, Snow GL, Schneider A, Lee JL, Ilstrup S, et al. Circadian and circannual rhythms in thyroid hormones: determining the TSH and Free T4 reference intervals based upon time of day, age, and sex. Thyroid 2015;25:954–61.10.1089/thy.2014.0589Search in Google Scholar PubMed
20. Clinical and Laboratory Standards Institute (CLSI). Defining, establishing and verifying reference intervals in the clinical laboratory. Approved guideline, 3rd ed. C28-A3c, 2008.Search in Google Scholar
21. Thienpont LM, Van Uytfanghe K, Van Houcke S, Das B, Faix JD, MacKenzie F, et al. A progress report of the IFCC committee for standardization of thyroid function tests. Eur Thyroid J 2014;3:109–16.10.1159/000358270Search in Google Scholar PubMed PubMed Central
22. Thienpont LM, Van Uytfanghe K, Beastall G, Faix JD, Ieiri T, Miller WG, et al. Report of the IFCC working group for standardization of thyroid function tests; part 1: thyroid-stimulating hormone. Clin Chem 2010;56:902–11.10.1373/clinchem.2009.140178Search in Google Scholar PubMed
23. Association of Clinical Biochemistry, British Thyroid Association, British Thyroid Foundation 2006. UK guidelines for the use of thyroid function tests.Search in Google Scholar
24. Anckaert E, Poppe K, Van Uytfanghe K, Schiettecatte J, Foulon W, Thienpont LM. FT4 immunoassays may display a pattern during pregnancy similar to the equilibrium dialysis ID-LC/tandem MS candidate reference measurement procedure in spite of susceptibility towards binding protein alterations. Clin Chim Acta 2010;411:1348–53.10.1016/j.cca.2010.05.032Search in Google Scholar PubMed
25. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocrine Rev 1997;18:404–33.10.1210/edrv.18.3.0300Search in Google Scholar PubMed
26. Gardner, Shoback, editors. Greenspan’s basic and clinical endocrinology, 9th ed. Chapter 7 The thyroid gland. New York: McGraw-Hill; 2011:181–2.Search in Google Scholar
©2016 by De Gruyter
Articles in the same Issue
- Frontmatter
- In Memoriam: Gérard Siest (1936–2016)
- Editorials
- Improving diagnosis and reducing diagnostic errors: the next frontier of laboratory medicine
- The quality indicator paradox
- Review
- Clinical utility of the (-2)proPSA and evaluation of the evidence: a systematic review
- Mini Review
- Why are clinical practice guidelines not followed?
- EFLM Position Paper
- Patient identification and tube labelling – a call for harmonisation
- Genetics and Molecular Diagnostics
- A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function
- Performance of two commercially available BCR-ABL1 quantification assays that use an international reporting scale
- HAND1 loss-of-function mutation associated with familial dilated cardiomyopathy
- General Clinical Chemistry and Laboratory Medicine
- Performance criteria and quality indicators for the post-analytical phase
- Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
- Quantitative determination of four immunosuppressants by high resolution mass spectrometry (HRMS)
- Measurement of plasma vitamin K1 (phylloquinone) and K2 (menaquinones-4 and -7) using HPLC-tandem mass spectrometry
- Therapeutic drug monitoring of infliximab: performance evaluation of three commercial ELISA kits
- High level of oxysterols in neonatal cholestasis: a pitfall in analysis of biochemical markers for Niemann-Pick type C disease
- Reference Values and Biological Variations
- Reference intervals of plasma homoarginine from the German Gutenberg Health Study
- TSH and fT4 during pregnancy: an observational study and a review of the literature
- Cancer Diagnostics
- Mean corpuscular volume levels and all-cause and liver cancer mortality
- Cardiovascular Diseases
- Circulating endothelial-derived apoptotic microparticles and insulin resistance in non-diabetic patients with chronic heart failure
- Hematology and Coagulation
- Platelet aggregation in response to ADP is highly variable in normal donors and patients on anti-platelet medication
- Letters to the Editor
- EQA-derived metrics to assess overall instrument performance
- Misidentification in laboratory medicine and diagnostic process: a neglected problem calling for action
- Impact of the routine implementation of automated indirect immunofluorescence antinuclear antibody analysis: 1 year of experience
- The importance of angiogenic markers in the differential diagnosis of HELLP syndrome vs. non-HELLP thrombocytopenia
- Bisalbuminemia accompanying bisalbuminuria detected in capillary electrophoresis, not in gel electrophoresis
- Prognostic value of red blood cell distribution width in acute pancreatitis patients admitted to intensive care units: an analysis of a publicly accessible clinical database MIMIC II
- Differences in analytical and biological results between older and newer lots of a widely used irisin immunoassay question the validity of previous studies
- A diagnostic algorithm for the detection of inhibitors against coagulation Factor V
- Interference of anticoagulants on coagulation testing
- Congress Abstracts
- Swiss MedLab 2016 and 74th Annual Meeting of the Swiss Society of Microbiology SSM, Bern, 13–16 June 2016
Articles in the same Issue
- Frontmatter
- In Memoriam: Gérard Siest (1936–2016)
- Editorials
- Improving diagnosis and reducing diagnostic errors: the next frontier of laboratory medicine
- The quality indicator paradox
- Review
- Clinical utility of the (-2)proPSA and evaluation of the evidence: a systematic review
- Mini Review
- Why are clinical practice guidelines not followed?
- EFLM Position Paper
- Patient identification and tube labelling – a call for harmonisation
- Genetics and Molecular Diagnostics
- A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function
- Performance of two commercially available BCR-ABL1 quantification assays that use an international reporting scale
- HAND1 loss-of-function mutation associated with familial dilated cardiomyopathy
- General Clinical Chemistry and Laboratory Medicine
- Performance criteria and quality indicators for the post-analytical phase
- Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
- Quantitative determination of four immunosuppressants by high resolution mass spectrometry (HRMS)
- Measurement of plasma vitamin K1 (phylloquinone) and K2 (menaquinones-4 and -7) using HPLC-tandem mass spectrometry
- Therapeutic drug monitoring of infliximab: performance evaluation of three commercial ELISA kits
- High level of oxysterols in neonatal cholestasis: a pitfall in analysis of biochemical markers for Niemann-Pick type C disease
- Reference Values and Biological Variations
- Reference intervals of plasma homoarginine from the German Gutenberg Health Study
- TSH and fT4 during pregnancy: an observational study and a review of the literature
- Cancer Diagnostics
- Mean corpuscular volume levels and all-cause and liver cancer mortality
- Cardiovascular Diseases
- Circulating endothelial-derived apoptotic microparticles and insulin resistance in non-diabetic patients with chronic heart failure
- Hematology and Coagulation
- Platelet aggregation in response to ADP is highly variable in normal donors and patients on anti-platelet medication
- Letters to the Editor
- EQA-derived metrics to assess overall instrument performance
- Misidentification in laboratory medicine and diagnostic process: a neglected problem calling for action
- Impact of the routine implementation of automated indirect immunofluorescence antinuclear antibody analysis: 1 year of experience
- The importance of angiogenic markers in the differential diagnosis of HELLP syndrome vs. non-HELLP thrombocytopenia
- Bisalbuminemia accompanying bisalbuminuria detected in capillary electrophoresis, not in gel electrophoresis
- Prognostic value of red blood cell distribution width in acute pancreatitis patients admitted to intensive care units: an analysis of a publicly accessible clinical database MIMIC II
- Differences in analytical and biological results between older and newer lots of a widely used irisin immunoassay question the validity of previous studies
- A diagnostic algorithm for the detection of inhibitors against coagulation Factor V
- Interference of anticoagulants on coagulation testing
- Congress Abstracts
- Swiss MedLab 2016 and 74th Annual Meeting of the Swiss Society of Microbiology SSM, Bern, 13–16 June 2016